Thoracic Hypofractionated Radiotherapy

RADIATION2 trials

Sponsors

First People's Hospital of Hangzhou

Conditions

EGFR Positive Non-small Cell Lung CancerLung Adenocarcinoma

Phase 2

Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy

First People's Hospital of HangzhouLung Adenocarcinoma

Start: 2016-05-31End: 2020-05-31Target: 46Updated: 2016-11-25

A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy

First People's Hospital of HangzhouEGFR Positive Non-small Cell Lung Cancer, Lung Adenocarcinoma

Start: 2016-05-31End: 2022-05-31Target: 76Updated: 2016-06-02